Inositec Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $119M

Inositec General Information

Description

Operator of a research and development company intended to offer soft tissue calcification disorders treatments. The company selectively replaces some or all of the phosphate groups on inositol phosphate with other chemical groups to tune the properties to obtain molecules with more favorable drug-like properties that can be tailored for use in different therapeutic indications, enabling doctors to treat cardiovascular and renal calcification disorders.

Contact Information

Website
www.inositec.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Technoparkstrasse 1
  • 8005 Zurich
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
CSL Vifor
Vertical(s)
Life Sciences
Corporate Office
  • Technoparkstrasse 1
  • 8005 Zurich
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inositec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 30-Nov-2021 $119M Completed Pre-Clinical Trials
7. Accelerator/Incubator 01-Sep-2020 Completed Startup
6. Seed Round 27-Oct-2016 Completed Startup
5. Grant 13-Nov-2015 Completed Startup
4. Accelerator/Incubator Completed Startup
3. Angel (individual) Completed Startup
2. Accelerator/Incubator 01-Jan-2015 Completed Startup
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Inositec’s complete valuation and funding history, request access »

Inositec Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
To view Inositec’s complete cap table history, request access »

Inositec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a research and development company intended to offer soft tissue calcification disorders treatments. The com
Drug Discovery
Zurich, Switzerland
6 As of 2021

New York, NY

New Haven, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inositec Competitors (57)

One of Inositec’s 57 competitors is Attune Pharmaceuticals, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Attune Pharmaceuticals Venture Capital-Backed New York, NY
Arvinas Formerly VC-backed New Haven, CT
Klotho Therapeutics Formerly VC-backed San Diego, CA
Altimmune Formerly VC-backed Gaithersburg, MD
Centrose Venture Capital-Backed Madison, WI
You’re viewing 5 of 57 competitors. Get the full list »

Inositec Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Inositec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022161980-A1 Clinical dosing schedule of inositol phosphate oligo(ethylene glycol) compounds Inactive 26-Jan-2021
WO-2022106657-A1 Inositol hexakisphosphate analogues for treatment of calcification associated kidney diseases Inactive 20-Nov-2020
US-20240336640-A1 Calcium oxalate crystallization inhibitors for renal disorders Pending 18-Sep-2018
WO-2020058321-A1 Calcium oxalate crystallization inhibitors for renal disorders Inactive 18-Sep-2018
US-20210290643-A1 Inositol derivatives for use in pathological crystallization Active 11-Dec-2015 A61K31/6615
To view Inositec’s complete patent history, request access »

Inositec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inositec Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
ETH Zurich University
Heuberger Winterthur Young Entrepreneurs Award Not-For-Profit Venture Capital
Venture (Switzerland) Accelerator/Incubator
Venture Kick Accelerator/Incubator
VentureOut (US) Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Inositec FAQs

  • When was Inositec founded?

    Inositec was founded in 2015.

  • Where is Inositec headquartered?

    Inositec is headquartered in Zurich, Switzerland.

  • What is the size of Inositec?

    Inositec has 6 total employees.

  • What industry is Inositec in?

    Inositec’s primary industry is Drug Discovery.

  • Is Inositec a private or public company?

    Inositec is a Private company.

  • What is the current valuation of Inositec?

    The current valuation of Inositec is .

  • What is Inositec’s current revenue?

    The current revenue for Inositec is .

  • How much funding has Inositec raised over time?

    Inositec has raised $1.44M.

  • Who are Inositec’s investors?

    ETH Zurich, Heuberger Winterthur Young Entrepreneurs Award, Venture (Switzerland), Venture Kick, and VentureOut (US) are 5 of 8 investors who have invested in Inositec.

  • Who are Inositec’s competitors?

    Attune Pharmaceuticals, Arvinas, Klotho Therapeutics, Altimmune, and Centrose are some of the 57 competitors of Inositec.

  • When was Inositec acquired?

    Inositec was acquired on 30-Nov-2021.

  • Who acquired Inositec?

    Inositec was acquired by CSL Vifor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process